Abeona Therapeutics Inc Cash Flow-to-Debt Ratio
Abeona Therapeutics Inc cash flow-to-debt ratio. Abeona Therapeutics Inc (ABEO) has a Cash Flow-to-Debt Ratio of -0.34x as of June 2026, meaning its operating cash flow of $-17.50 Million could theoretically repay 0% of its total liabilities ($51.45 Million) in one year. Check Abeona Therapeutics Inc (ABEO) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Abeona Therapeutics Inc (1995–2025)
Cash flow-to-debt ratio of Abeona Therapeutics Inc from 1995 to 2025. Historical debt coverage capacity for Abeona Therapeutics Inc across 31 annual periods. Check ABEO cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Abeona Therapeutics Inc Cash Flow-to-Debt Ratio by Year (1995–2025)
Abeona Therapeutics Inc cash flow-to-debt ratio by year from 1995 to 2025. Year-by-year debt coverage analysis for Abeona Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Abeona Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.26x | $-76.33 Million | $60.35 Million | ▼ -46.5% |
| 2024 | -0.86x | $-56.02 Million | $64.90 Million | ▼ -14.7% |
| 2023 | -0.75x | $-37.01 Million | $49.18 Million | ▲ +35.2% |
| 2022 | -1.16x | $-43.48 Million | $37.45 Million | ▲ +34.2% |
| 2021 | -1.76x | $-65.67 Million | $37.22 Million | ▼ -145.1% |
| 2020 | -0.72x | $-35.02 Million | $48.65 Million | ▲ +48.5% |
| 2019 | -1.40x | $-62.82 Million | $44.95 Million | ▼ -44.2% |
| 2018 | -0.97x | $-39.11 Million | $40.35 Million | ▲ +63.4% |
| 2017 | -2.65x | $-22.93 Million | $8.67 Million | ▼ -143.2% |
| 2016 | -1.09x | $-13.01 Million | $11.96 Million | ▼ -28.8% |
| 2015 | -0.85x | $-10.42 Million | $12.33 Million | ▼ -517.2% |
| 2014 | -0.14x | $-1.61 Million | $11.77 Million | ▼ -210847.2% |
| 2013 | 0.00x | $1.00K | $15.39 Million | ▲ +100.0% |
| 2012 | -0.21x | $-3.96 Million | $18.81 Million | ▲ +40.9% |
| 2011 | -0.36x | $-7.61 Million | $21.39 Million | ▼ -53.3% |
| 2010 | -0.23x | $-6.86 Million | $29.57 Million | ▼ -194.9% |
| 2009 | -0.08x | $-2.25 Million | $28.57 Million | ▲ +81.6% |
| 2008 | -0.43x | $-6.56 Million | $15.36 Million | ▼ -174.7% |
| 2007 | 0.57x | $4.84 Million | $8.47 Million | ▲ +576.5% |
| 2006 | -0.12x | $-1.96 Million | $16.31 Million | ▲ +81.2% |
| 2005 | -0.64x | $-7.30 Million | $11.45 Million | ▼ -24.7% |
| 2004 | -0.51x | $-9.08 Million | $17.75 Million | ▼ -41.7% |
| 2003 | -0.36x | $-6.36 Million | $17.64 Million | ▲ +20.3% |
| 2002 | -0.45x | $-8.60 Million | $19.00 Million | ▼ -40.8% |
| 2001 | -0.32x | $-5.27 Million | $16.41 Million | ▼ -15.1% |
| 2000 | -0.28x | $-4.33 Million | $15.52 Million | ▲ +91.4% |
| 1999 | -3.25x | $-3.25 Million | $1.00 Million | ▲ +39.2% |
| 1998 | -5.33x | $-3.20 Million | $600.00K | ▼ -24.7% |
| 1997 | -4.28x | $-3.63 Million | $848.00K | ▼ -39.2% |
| 1996 | -3.07x | $-2.67 Million | $868.00K | ▼ -306.9% |
| 1995 | 1.49x | $658.00K | $443.00K | — |